Opioid Use Disorder affects millions of lives
worldwide annually. Opioids are drugs that provide pain relief but also produce
feelings of euphoria and a relaxation of the body. Due to their addictive
properties, continuous use of opioids can lead to developing Opioid Use
Disorder characterized by strong cravings and compulsive use. Buprenorphine and
methadone are effective therapies for treating Opioid Use Disorder by reducing
withdrawal symptoms and relieving drug cravings without producing pleasurable
effects.
The global Opioid Use Disorder Market is
estimated to be valued at US$ 3236.55 Mn in 2023 and is expected to exhibit a
CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of Opioid Use Disorder worldwide has accelerated the
growth of the Opioid Use Disorder Market. As per estimates, around 35 million
people suffer from Opioid Use Disorder globally. Easy availability and misuse
of prescription opioids have resulted in high rates of addiction. Growing
awareness among communities regarding treatment options and decreasing social
stigma associated with Opioid Use Disorder are also contributing to the market
growth. Expanding reimbursement programs favorable to Medication-Assisted
Treatment in many countries have further supported the increasing adoption of
buprenorphine and methadone therapies over the forecast period.
Segment
Analysis
The global Opioid Use Disorder market is dominated by the opioid maintenance
treatment sub-segment, which held around 60% market share in 2024. Opioid
maintenance treatment helps minimize withdrawal symptoms and reduce drug
cravings in patients with opioid addiction. Wide availability of drugs such as
buprenorphine and methadone for opioid maintenance treatment and their
effectiveness in controlling withdrawal symptoms has boosted the growth of this
sub-segment over the forecast period.
Key Takeaways
Global
Opioid Use Disorder Market Demand is expected to witness high growth
over the forecast period of 2023 to 2030. The growing incidence of opioid abuse
disorders and increasing government support for treatment of opioid addiction
are driving the market.
Regional analysis: North America dominated the global market with over 40%
share in 2024 owing to high incidence of opioid abuse disorders and presence of
advanced healthcare facilities for treatment in the region. Asia Pacific is
expected to witness fastest growth during the forecast period supported by
growing awareness, improving healthcare infrastructure and increasing funding
for treatment of substance abuse disorders in emerging countries of the region.
Key players analysis: Key players operating in the Opioid Use Disorder market
are Moog Inc., Honeywell International Inc., AMETEK Inc., TE Connectivity,
Woodward Inc., General Dynamics Corporation, Parker Hannifin Corp, Sensata
Technologies, Tamagawa Seiki Co., Ltd., LTN Servotechnik GmbH, Maxon Group,
Bevone, Danaher Corporation, Kollmorgen, TE Connectivity, ALXION, Micronor,
Elmo Motion Control, Electro-Sensors, Siko GmbH. Moog Inc emerged as the
leading player with over 15% market share in 2024 attributed to its strong
portfolio of opioid dependence treatment drugs such as Suboxone.
Comments
Post a Comment